Problem: The term patient experience data was amended to include the physical and psychological impacts of disease of a condition or its related therapy and clinical investigations that are relevant; this was amended in 2017 with the Food and Drug Reauthorization Act and is crucial to continue to revisit ethical principles that were established in the Belmont Report.